COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS

This invention relates to compounds of the Formula (I)-(IX):, as defined herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- a combinations thereof. L'invention...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHEN, LEI, RICHARD, JUDSON, E, LAVEY, BRIAN, J, LI, DANSU, WONG, MICHAEL, K., C, SHANKAR, BANDARPALLE, B, KOZLOWSKI, JOSEPH, A, KOSINSKI, ANETA, MARIA, TONG, LING, RIZVI, RAZIA, K, YU, WENSHENG, ZHOU, GUOWEI, ROSNER, KRISTEN, E, FIRE, LUKE, KIM, SEONG, HEON, YANG, DE-YI
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention relates to compounds of the Formula (I)-(IX):, as defined herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- a combinations thereof. L'invention concerne des composés de la formule (I) à (IX), tels que définis dans la description, ou un sel, un solvate ou un ester pharmaceutiquement acceptable de ces composés, qui peuvent être utiles pour le traitement de maladies ou d'états pathologiques médiés par les MMP, ADAM, TACE, agrécanase, TNF-a ou leurs combinaisons.